BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chokkalla AK, Mehta SL, Vemuganti R. Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases. J Cereb Blood Flow Metab 2020;40:2331-49. [PMID: 32967524 DOI: 10.1177/0271678X20960033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian M, Mao L, Zhang L. Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries. Front Cell Neurosci 2022;16:1013450. [DOI: 10.3389/fncel.2022.1013450] [Reference Citation Analysis]
2 Xu Z, Jiang J, Wang S. The Critical Role of RNA m6A Methylation in Gliomas: Targeting the Hallmarks of Cancer. Cell Mol Neurobiol. [DOI: 10.1007/s10571-022-01283-8] [Reference Citation Analysis]
3 Luo N, Fu M, Zhang Y, Li X, Zhu W, Yang F, Chen Z, Mei Q, Peng X, Shen L, Zhang Y, Li Q, Hu G. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma. Front Cell Dev Biol 2022;10:935135. [DOI: 10.3389/fcell.2022.935135] [Reference Citation Analysis]
4 Chokkalla AK, Pajdzik K, Dou X, Dai Q, Mehta SL, Arruri V, Vemuganti R. Dysregulation of the Epitranscriptomic Mark m1A in Ischemic Stroke. Transl Stroke Res 2022. [PMID: 35737185 DOI: 10.1007/s12975-022-01056-x] [Reference Citation Analysis]
5 Li W, Li X, Ma X, Xiao W, Zhang J. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq. BMC Genomics 2022;23:105. [PMID: 35135476 DOI: 10.1186/s12864-022-08350-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang N, Ding C, Zuo Y, Peng Y, Zuo L. N6-methyladenosine and Neurological Diseases. Mol Neurobiol 2022. [PMID: 35032318 DOI: 10.1007/s12035-022-02739-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
7 Chen L, Li Z, Zhang S, Zhang Y, Huang T, Cai Y, Ali HH. Predicting RNA 5-Methylcytosine Sites by Using Essential Sequence Features and Distributions. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/4035462] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
8 Kumar R, Khandelwal N, Chander Y, Nagori H, Verma A, Barua A, Godara B, Pal Y, Gulati BR, Tripathi BN, Barua S, Kumar N. S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants. Antiviral Res 2021;:105232. [PMID: 34968527 DOI: 10.1016/j.antiviral.2021.105232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 Chang LL, Xu XQ, Liu XL, Guo QQ, Fan YN, He BX, Zhang WZ. Emerging role of m6A methylation modification in ovarian cancer. Cancer Cell Int 2021;21:663. [PMID: 34895230 DOI: 10.1186/s12935-021-02371-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ji F, Lu Y, Chen S, Lin X, Yu Y, Zhu Y, Luo X. m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer. Mol Ther Oncolytics 2021;22:574-81. [PMID: 34589576 DOI: 10.1016/j.omto.2021.07.004] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
11 Liu Z, Li S, Huang S, Wang T, Liu Z. N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling. Front Oncol 2021;11:704543. [PMID: 34395276 DOI: 10.3389/fonc.2021.704543] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Li Q, Wen S, Ye W, Zhao S, Liu X. The potential roles of m6A modification in regulating the inflammatory response in microglia. J Neuroinflammation 2021;18:149. [PMID: 34225746 DOI: 10.1186/s12974-021-02205-z] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
13 Chokkalla AK, Mehta SL, Vemuganti R. Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS. Transl Stroke Res 2021. [PMID: 34224107 DOI: 10.1007/s12975-021-00927-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yen YP, Chen JA. The m6A epitranscriptome on neural development and degeneration. J Biomed Sci 2021;28:40. [PMID: 34039354 DOI: 10.1186/s12929-021-00734-6] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
15 Sokpor G, Xie Y, Nguyen HP, Tuoc T. Emerging Role of m6 A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment. Front Cell Dev Biol 2021;9:656849. [PMID: 34095121 DOI: 10.3389/fcell.2021.656849] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Wilkinson E, Cui YH, He YY. Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases. Int J Mol Sci 2021;22:1949. [PMID: 33669361 DOI: 10.3390/ijms22041949] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
17 Destefanis E, Avşar G, Groza P, Romitelli A, Torrini S, Pir P, Conticello SG, Aguilo F, Dassi E. A mark of disease: how mRNA modifications shape genetic and acquired pathologies. RNA 2021;27:367-89. [PMID: 33376192 DOI: 10.1261/rna.077271.120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]